EXELA PHARMA SCIENCES LLC has sponsored the creation of one or more 401k plans.
Submission information for form 5500 for 401k plan EXELA PHARMA 401 K PROFIT SHARING PLAN TRUST
Measure | Date | Value |
---|
2022 : EXELA PHARMA 401 K PROFIT SHARING PLAN TRUST 2022 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
Total transfer of assets to this plan | 2022-12-31 | $0 |
Total transfer of assets from this plan | 2022-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total income from all sources (including contributions) | 2022-12-31 | $623,296 |
Total loss/gain on sale of assets | 2022-12-31 | $0 |
Total of all expenses incurred | 2022-12-31 | $641,406 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $580,872 |
Expenses. Certain deemed distributions of participant loans | 2022-12-31 | $6,120 |
Value of total corrective distributions | 2022-12-31 | $431 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $2,303,922 |
Value of total assets at end of year | 2022-12-31 | $8,894,842 |
Value of total assets at beginning of year | 2022-12-31 | $8,912,952 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $53,983 |
Total interest from all sources | 2022-12-31 | $5,451 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $343,641 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $343,641 |
Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
Value of fidelity bond cover | 2022-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Contributions received from participants | 2022-12-31 | $1,313,940 |
Participant contributions at end of year | 2022-12-31 | $142,266 |
Participant contributions at beginning of year | 2022-12-31 | $117,505 |
Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $357,604 |
Administrative expenses (other) incurred | 2022-12-31 | $53,983 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Value of net income/loss | 2022-12-31 | $-18,110 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $8,894,842 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $8,912,952 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $8,295,129 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $8,401,671 |
Interest on participant loans | 2022-12-31 | $5,451 |
Value of interest in common/collective trusts at end of year | 2022-12-31 | $457,447 |
Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $393,776 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-2,036,815 |
Net investment gain or loss from common/collective trusts | 2022-12-31 | $7,097 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
Contributions received in cash from employer | 2022-12-31 | $632,378 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $580,872 |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
Accountancy firm name | 2022-12-31 | FORVIS, LLP |
Accountancy firm EIN | 2022-12-31 | 440160260 |
2021 : EXELA PHARMA 401 K PROFIT SHARING PLAN TRUST 2021 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
Total transfer of assets to this plan | 2021-12-31 | $0 |
Total transfer of assets from this plan | 2021-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total income from all sources (including contributions) | 2021-12-31 | $2,659,615 |
Total loss/gain on sale of assets | 2021-12-31 | $0 |
Total of all expenses incurred | 2021-12-31 | $732,296 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $684,006 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $1,627,917 |
Value of total assets at end of year | 2021-12-31 | $8,912,952 |
Value of total assets at beginning of year | 2021-12-31 | $6,985,633 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $48,290 |
Total interest from all sources | 2021-12-31 | $5,079 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $465,245 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $465,245 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2021-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $1,023,612 |
Participant contributions at end of year | 2021-12-31 | $117,505 |
Participant contributions at beginning of year | 2021-12-31 | $118,965 |
Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $131,790 |
Administrative expenses (other) incurred | 2021-12-31 | $48,290 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $1,927,319 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $8,912,952 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $6,985,633 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $8,401,671 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $6,524,571 |
Interest on participant loans | 2021-12-31 | $5,079 |
Value of interest in common/collective trusts at end of year | 2021-12-31 | $393,776 |
Value of interest in common/collective trusts at beginning of year | 2021-12-31 | $342,097 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $555,701 |
Net investment gain or loss from common/collective trusts | 2021-12-31 | $5,673 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Contributions received in cash from employer | 2021-12-31 | $472,515 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $684,006 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
Accountancy firm name | 2021-12-31 | FORVIS, LLP |
Accountancy firm EIN | 2021-12-31 | 440160260 |
2020 : EXELA PHARMA 401 K PROFIT SHARING PLAN TRUST 2020 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
Total transfer of assets to this plan | 2020-12-31 | $0 |
Total transfer of assets from this plan | 2020-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total income from all sources (including contributions) | 2020-12-31 | $2,424,290 |
Total loss/gain on sale of assets | 2020-12-31 | $0 |
Total of all expenses incurred | 2020-12-31 | $502,073 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $468,309 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $1,340,765 |
Value of total assets at end of year | 2020-12-31 | $6,985,633 |
Value of total assets at beginning of year | 2020-12-31 | $5,063,416 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $33,764 |
Total interest from all sources | 2020-12-31 | $5,064 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $213,820 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $213,820 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $500,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2020-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Contributions received from participants | 2020-12-31 | $872,050 |
Participant contributions at end of year | 2020-12-31 | $118,965 |
Participant contributions at beginning of year | 2020-12-31 | $85,998 |
Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $54,698 |
Administrative expenses (other) incurred | 2020-12-31 | $33,764 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $1,922,217 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $6,985,633 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $5,063,416 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $6,524,571 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $4,726,535 |
Interest on participant loans | 2020-12-31 | $5,064 |
Value of interest in common/collective trusts at end of year | 2020-12-31 | $342,097 |
Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $250,883 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $858,912 |
Net investment gain or loss from common/collective trusts | 2020-12-31 | $5,729 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $414,017 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $468,309 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
Accountancy firm name | 2020-12-31 | DIXON HUGHES GOODMAN LLP |
Accountancy firm EIN | 2020-12-31 | 560747981 |
2019 : EXELA PHARMA 401 K PROFIT SHARING PLAN TRUST 2019 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
Total transfer of assets to this plan | 2019-12-31 | $0 |
Total transfer of assets from this plan | 2019-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total income from all sources (including contributions) | 2019-12-31 | $1,985,088 |
Total loss/gain on sale of assets | 2019-12-31 | $0 |
Total of all expenses incurred | 2019-12-31 | $853,571 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $824,947 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $1,125,814 |
Value of total assets at end of year | 2019-12-31 | $5,063,416 |
Value of total assets at beginning of year | 2019-12-31 | $3,931,899 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $28,624 |
Total interest from all sources | 2019-12-31 | $4,494 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $203,351 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $203,351 |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Value of fidelity bond cover | 2019-12-31 | $394,000 |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2019-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Contributions received from participants | 2019-12-31 | $750,250 |
Participant contributions at end of year | 2019-12-31 | $85,998 |
Participant contributions at beginning of year | 2019-12-31 | $103,201 |
Administrative expenses (other) incurred | 2019-12-31 | $28,624 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Value of net income/loss | 2019-12-31 | $1,131,517 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $5,063,416 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $3,931,899 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $4,726,535 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $3,637,589 |
Interest on participant loans | 2019-12-31 | $4,494 |
Value of interest in common/collective trusts at end of year | 2019-12-31 | $250,883 |
Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $191,109 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $646,683 |
Net investment gain or loss from common/collective trusts | 2019-12-31 | $4,746 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Contributions received in cash from employer | 2019-12-31 | $375,564 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $824,947 |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Accountancy firm name | 2019-12-31 | DIXON HUGHES GOODMAN LLP |
Accountancy firm EIN | 2019-12-31 | 560747981 |
2018 : EXELA PHARMA 401 K PROFIT SHARING PLAN TRUST 2018 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2018-12-31 | $0 |
Total transfer of assets to this plan | 2018-12-31 | $0 |
Total transfer of assets from this plan | 2018-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
Total income from all sources (including contributions) | 2018-12-31 | $775,528 |
Total loss/gain on sale of assets | 2018-12-31 | $0 |
Total of all expenses incurred | 2018-12-31 | $193,219 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $173,992 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $963,641 |
Value of total assets at end of year | 2018-12-31 | $3,931,899 |
Value of total assets at beginning of year | 2018-12-31 | $3,349,590 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $19,227 |
Total interest from all sources | 2018-12-31 | $4,626 |
Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $200,910 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $200,910 |
Was this plan covered by a fidelity bond | 2018-12-31 | Yes |
Value of fidelity bond cover | 2018-12-31 | $335,000 |
If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2018-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
Contributions received from participants | 2018-12-31 | $620,425 |
Participant contributions at end of year | 2018-12-31 | $103,201 |
Participant contributions at beginning of year | 2018-12-31 | $67,989 |
Participant contributions at beginning of year | 2018-12-31 | $18,691 |
Income. Received or receivable in cash from other sources (including rollovers) | 2018-12-31 | $32,188 |
Administrative expenses (other) incurred | 2018-12-31 | $19,227 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Value of net income/loss | 2018-12-31 | $582,309 |
Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $3,931,899 |
Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $3,349,590 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $3,637,589 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $3,124,008 |
Interest on participant loans | 2018-12-31 | $4,626 |
Value of interest in common/collective trusts at end of year | 2018-12-31 | $191,109 |
Value of interest in common/collective trusts at beginning of year | 2018-12-31 | $129,480 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-396,508 |
Net investment gain or loss from common/collective trusts | 2018-12-31 | $2,859 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
Contributions received in cash from employer | 2018-12-31 | $311,028 |
Employer contributions (assets) at beginning of year | 2018-12-31 | $9,422 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $173,992 |
Did the plan have assets held for investment | 2018-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Disclaimer |
Accountancy firm name | 2018-12-31 | DIXON HUGHES GOODMAN LLP |
Accountancy firm EIN | 2018-12-31 | 560747981 |
2017 : EXELA PHARMA 401 K PROFIT SHARING PLAN TRUST 2017 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2017-12-31 | $0 |
Total transfer of assets to this plan | 2017-12-31 | $0 |
Total transfer of assets from this plan | 2017-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total income from all sources (including contributions) | 2017-12-31 | $1,260,046 |
Total loss/gain on sale of assets | 2017-12-31 | $0 |
Total of all expenses incurred | 2017-12-31 | $324,717 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $314,871 |
Expenses. Certain deemed distributions of participant loans | 2017-12-31 | $5,733 |
Value of total corrective distributions | 2017-12-31 | $1,915 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $858,443 |
Value of total assets at end of year | 2017-12-31 | $3,349,590 |
Value of total assets at beginning of year | 2017-12-31 | $2,414,261 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $2,198 |
Total interest from all sources | 2017-12-31 | $1,851 |
Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $127,725 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2017-12-31 | $127,725 |
Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
Value of fidelity bond cover | 2017-12-31 | $242,000 |
If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2017-12-31 | $0 |
Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
Contributions received from participants | 2017-12-31 | $508,654 |
Participant contributions at end of year | 2017-12-31 | $67,989 |
Participant contributions at beginning of year | 2017-12-31 | $45,988 |
Participant contributions at end of year | 2017-12-31 | $18,691 |
Income. Received or receivable in cash from other sources (including rollovers) | 2017-12-31 | $109,123 |
Administrative expenses (other) incurred | 2017-12-31 | $2,198 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Value of net income/loss | 2017-12-31 | $935,329 |
Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $3,349,590 |
Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $2,414,261 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $3,124,008 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $2,277,654 |
Interest on participant loans | 2017-12-31 | $1,851 |
Value of interest in common/collective trusts at end of year | 2017-12-31 | $129,480 |
Value of interest in common/collective trusts at beginning of year | 2017-12-31 | $90,619 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $270,895 |
Net investment gain or loss from common/collective trusts | 2017-12-31 | $1,132 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
Contributions received in cash from employer | 2017-12-31 | $240,666 |
Employer contributions (assets) at end of year | 2017-12-31 | $9,422 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $314,871 |
Did the plan have assets held for investment | 2017-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Disclaimer |
Accountancy firm name | 2017-12-31 | DIXON HUGHES GOODMAN, LLP |
Accountancy firm EIN | 2017-12-31 | 560747981 |
2016 : EXELA PHARMA 401 K PROFIT SHARING PLAN TRUST 2016 401k financial data |
---|
Total unrealized appreciation/depreciation of assets | 2016-12-31 | $0 |
Total transfer of assets from this plan | 2016-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total income from all sources (including contributions) | 2016-12-31 | $781,344 |
Total loss/gain on sale of assets | 2016-12-31 | $0 |
Total of all expenses incurred | 2016-12-31 | $37,850 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $36,183 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $642,972 |
Value of total assets at end of year | 2016-12-31 | $2,414,261 |
Value of total assets at beginning of year | 2016-12-31 | $1,670,767 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-12-31 | $1,667 |
Total interest from all sources | 2016-12-31 | $672 |
Total dividends received (eg from common stock, registered investment company shares) | 2016-12-31 | $69,786 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2016-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2016-12-31 | $69,786 |
Was this plan covered by a fidelity bond | 2016-12-31 | Yes |
Value of fidelity bond cover | 2016-12-31 | $168,000 |
If this is an individual account plan, was there a blackout period | 2016-12-31 | Yes |
Were there any nonexempt tranactions with any party-in-interest | 2016-12-31 | No |
Contributions received from participants | 2016-12-31 | $432,148 |
Participant contributions at end of year | 2016-12-31 | $45,988 |
Participant contributions at beginning of year | 2016-12-31 | $19,487 |
Income. Received or receivable in cash from other sources (including rollovers) | 2016-12-31 | $16,449 |
Administrative expenses (other) incurred | 2016-12-31 | $1,667 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Value of net income/loss | 2016-12-31 | $743,494 |
Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $2,414,261 |
Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $1,670,767 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2016-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2016-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2016-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2016-12-31 | $2,277,654 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2016-12-31 | $1,651,280 |
Interest on participant loans | 2016-12-31 | $672 |
Value of interest in common/collective trusts at end of year | 2016-12-31 | $90,619 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2016-12-31 | $67,621 |
Net investment gain or loss from common/collective trusts | 2016-12-31 | $293 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2016-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2016-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2016-12-31 | No |
Contributions received in cash from employer | 2016-12-31 | $194,375 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2016-12-31 | $36,183 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2016-12-31 | Yes |
Did the plan have assets held for investment | 2016-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2016-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2016-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2016-12-31 | Disclaimer |